The efficacy of recombinant human soluble thrombomodulin (rhsTM) treatment for acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis. This evidence concerns the gene THBD and idiopathic pulmonary fibrosis.